FDA Moves Cannabis to Schedule Three, Boosting Industry

U.S. government reschedules cannabis, boosting stocks of major players like Cronos Group, Aurora Cannabis, Canopy Growth, and Tilray Brands. The move, announced by Acting Attorney General Todd Blanche, could expedite research, improve access, and integrate medical cannabis into healthcare with better safety standards. The change also eliminates harsh tax rules and opens doors to normal banking and investors, marking a significant step in the green rush. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0f26f0f8ae61f2c4